Hospira Reports Third-Quarter 20...(Nine Months Ended ...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Hospira Reports Third-Quarter 2009 Results
Date:10/27/2009
Nine Months Ended September 30, --------------- 2009 2008 ------- ------ Cash Flow From Operating Activities: Net income $307.2 $216.3 Adjustments to reconcile net income to net cash from operating activities- Depreciation 126.4 141.2 Amortization of intangible assets 45.9 51.1 Write-off of acquired in-process research and development - 0.5 Stock-based compensation expense 31.5 33.2 Deferred income tax and other tax adjustments (84.3) 1.9 Impairment and other asset charges 83.4 - Net gains on sales of assets - (3.0) Changes in assets and liabilities- Trade receivables 10.9 (75.8) Inventories (17.7) (107.6) Prepaid expenses and other assets 2.6 4.1 Trade accounts payable (34.2) 7.3 Other liabilities 90.6 37.1 Other, net (21.1) 22.3 ------- ------ Net Cash Provided by Operating Activities 541.2 328.6 ------- ------ Cash Flow From Investing Activities: Capital expenditures (including instruments placed with or leased
'/>"/>
| SOURCE Hospira, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
2. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
3. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
4. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
5. Hospira Names Daphne E. Jones Chief Information Officer
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
(Date:11/30/2009)...v. 30 Reportlinker.com announces t...ts catalogue: ,, Decubitus Ulcer Treatment Pro...ww.reportlinker.com/p0164283/Decubitus-Ulcer-Treat..., Decubitus Ulcers are lesions resulting from t...tient,s bodyweight. Pressure ulcer treatment produ...
(Date:11/30/2009)...v. 30 The Simmons law firm,s Trent...presenting thousands of women that were seriously ...th control pill manufactured and marketed by Bayer... Multidistrict Litigation has ordered that all fed... consolidated and centralized for pretrial litigat...
(Date:11/30/2009)...0 Minimally-invasive procedures ar... particularly in oncology, cardiology and women,s ...ge-guided navigation expected to reach $600 millio... offered by minimally-invasive procedures, includi... comfort and faster patient throughput. ,, (L...
Breaking Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Backyard Raccoon Latrines Harbor Hidden Dangers 54549 1Backyard Raccoon Latrines Harbor Hidden Dangers 54549 2Backyard Raccoon Latrines Harbor Hidden Dangers 54549 3UOG scientists successfully compete for research grants 9577 1UOG scientists successfully compete for research grants 9577 2New strategy for inhibiting virus replication 9572 1New strategy for inhibiting virus replication 9572 2...N THE JOURNAL OF DERMATOLOGIC SURGERY -, SAN MATE... BFRM ) today announced the publication of a post-...rative study of nasolabial fold,treatments reporti...significantly more effective than Restylane(R), th...he results of this study will be published in the,...
...a.m. ET Today, SOUTH SAN FRANCISCO, Calif., Jan. ...unced that the Independent Data,Monitoring Committ...ase 3,clinical trials of GVAX immunotherapy for pr... analysis and has recommended that the study conti...ed to determine whether the,study should continue ...
Other Medicine Technology:RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial 2RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial 3RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial 4Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 2Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 3Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 4(Date:11/30/2009)...13 chest X-rays, study finds , , MONDAY,...ients who have abdominal/pelvic CT scans receive a...em to extra radiation, U.S. researchers say. , ...ere performed on 500 patients aged 9 months to 91 ... age. The researchers concluded that 35.3 percent ...
(Date:11/30/2009)... in child deaths linked to flu, , , MON...cials said Monday that H1N1 swine flu infections a...mber of American children dying from the illness c... Monday by the U.S. Centers for Disease Control an...for influenza-like illness nationally decreased sh...
(Date:11/30/2009)...SNewswire/ -- SEIU Local 21LA members and New Orle...l hold a rally Tuesday, Dec. 1, 2009, at noon at S...0 Desire Parkway, New Orleans, to protest an unrea...licies that target employees who are ill or who ne...ees who clean schools in the Recovery School Distr...
(Date:11/30/2009)...swire-FirstCall/ -- Jedi Mind, Inc . (Pink Sheets...ce the Company,s first thought-controlled game is ...ink-Tac-Toe" is the first of its kind, which allow...r mind and is geared towards people of all ages. T...can be purchased directly through the Company by c...
(Date:11/30/2009)...nt To Simulate High Altitude, Low O2 Conditions ...- Distance runners who live at high altitudes with...ormance during races in areas that are at sea leve...atigue, improve their exercise performance by stay... That is the question being studied among 15 heart...
Breaking Medicine News(10 mins):Health News:CT Scan Patients May Get Unnecessary Imaging 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 3Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4[0] CT Scan Patients May Get Unnecessary Imaging[0] U.S. Swine Flu Cases Chart Sharp Decline[0] As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness[0] First Thought-Controlled Game Complete From Jedi Mind, Inc.[0] Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients?
... Management Health Solutions, Inc. (MHS),...gement solutions to the health care industry, anno...ting Group, a firm specializing in medical supply ...ch 26, 2009-- Management Health Solutions, Inc. (...
... March 26 Michigan State Board of Education Presi...ional Federation of the Blind of Michigan to launc... at 10:30 am in the Rotunda of the Michigan State... Michigan is joining in a nationwide campaign to d...
...h 25 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS...4th Annual Biotech Day on Wednesday, April 1, 2009...e will be held at the 388 Greenwich Street Confere...pdate on its ANA598 clinical program in hepatitis ...
...., March 25 Endo Pharmaceuticals Solutions Inc. (...oday commenced an offer to purchase any or all of ... 2009 in accordance with the indenture governing t....m., Eastern time, on April 22, 2009. , , In the ...
... Service Helps Manage Insurance Plan Authorization...., March 25 Recondo Technology, a leading provide...dustry, today announced the release schedule of Au...5 percent of all payer-denied claims, and can resu...
...March 25 The Texas Medical Association (TMA) join...day that would make using health insurance better ...lem: Too often patients do not understand their he...," said Josie R. Williams, M.D., TMA,s president. ...
Other Medicine News:Health News:Management Health Solutions, Inc. Selects NCI Consulting Group as Dedicated Representative to IDN's and GPO's 2Health News:Kathleen Strauss to Help Launch Braille Literacy Campaign 2Health News:Anadys Pharmaceuticals to Present at the Citi Biotech Day 2Health News:Endo Pharmaceuticals Solutions (Formerly Indevus Pharmaceuticals, Inc.) Announces Commencement of Offer to Purchase Its 6.25% Convertible Senior Notes Due 2009 2Health News:Endo Pharmaceuticals Solutions (Formerly Indevus Pharmaceuticals, Inc.) Announces Commencement of Offer to Purchase Its 6.25% Convertible Senior Notes Due 2009 3Health News:Recondo Technology Announces Authorization and Denial Prevention Software Service 2Health News:TMA Physicians and Legislators: 'Patients Have a Right to Know' 2Health News:TMA Physicians and Legislators: 'Patients Have a Right to Know' 3Management Health Solutions, Inc. Selects NCI Consulting Group as Dedicated Representative to IDN's and GPO'sKathleen Strauss to Help Launch Braille Literacy CampaignAnadys Pharmaceuticals to Present at the Citi Biotech DayEndo Pharmaceuticals Solutions (Formerly Indevus Pharmaceuticals, Inc.) Announces Commencement of Offer to Purchase Its 6.25% Convertible Senior Notes Due 2009Recondo Technology Announces Authorization and Denial Prevention Software ServiceTMA Physicians and Legislators: 'Patients Have a Right to Know'
BTC/1Q - Cast Aluminum Base - Model 1Q70-R
BTT/1P - Tubular Base - Model 1P61-R
BTT/1P - Tubular Base - Model 1P62
BTT/1P - Tubular Base - Model 1P61
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |